bioRxivBioinformaticsPreprint
Integrated Transcriptomic and Structural Prioritization of Sulforaphane Targets in Neurodegeneration: A Multi-Dataset In Silico Study
Abstract
Sulforaphane (SFN), a natural isothiocyanate from cruciferous vegetables, exerts neuroprotective effects through mechanisms extending beyond canonical Nrf2/ARE activation. Here, we developed a multi-dataset computational framework integrating transcriptomic analysis, multi-criteria target prioritization, and structural docking evaluation. R- and S-SFN were docked against 693 prioritized targets using AutoDock Vina, followed by cross-validation, brain expression profiling, and molecular dynamics simulations. Four genes (IGSF9, KCNQ5, KCTD12, and NFIX) were dysregulated across all four datasets. Among 693 targets, 88 showed favorable predicted docking scores (deltaG less than or equal to -4.0 kcal/mol), with 65 (73.9%) exhibiting expression in at least one GTEx brain region. Independent cross-validation showed significant enrichment of prioritized targets in an SFN-responsive Alzheimer disease transcriptomic dataset (OR = 1.44, 95% CI: 1.08-1.89, p = 0.0104). Complementary disease gene set enrichment confirmed that 33% of strong hits (29/88) overlap established neurodegeneration gene sets across AD, PD, and ALS - including ACHE, target of FDA-approved anti-AD drugs - with highly significant enrichment across all three disease categories (OR range: 67-127, all p less than 0.001). R-SFN showed a modest but statistically detectable preference over S-SFN across the 88 strong hits (Wilcoxon p = 0.0081; paired t-test p = 0.0047). TMEM45A, GRIK2, and FABP3 emerged as putative neurodegeneration-relevant targets. Molecular dynamics simulations supported the structural stability of R-SFN poses for TMEM45A, GRIK2, and FABP3, while MM-GBSA estimated favorable binding energies for GRIK2 (deltaG_bind = -19.78 kcal/mol) and FABP3 (deltaG_bind = -14.49 kcal/mol). These findings generate testable hypotheses regarding previously underexplored molecular targets that may contribute to the neuroprotective actions of SFN.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exploring the Antidepressant Effects of Saffron Constituents: Targeting Dopamine and Serotonin Transport Proteins, and Monoamine Oxidase-B: An in Silico Evidence-Based Study
Brijendra Bahadur Singh, Deepak sharma, … Vinay Lomash·bioRxiv·Mar 19, 2026
- In silico analysis of Bacopa monnieri (L.) Wettst. compounds for drug development against Neurodegenerative Disorders
S. Sangeet, A. Khan, … P. K. Hui·bioRxiv·Mar 30, 2022
- Transcriptome Network Biology Reveals the Neuroprotective Potential of Rosmarinic Acid Against Frontotemporal Dementia
Amaan Arif, Prekshi Garg, Prachi Srivastava·bioRxiv·Sep 5, 2025
- A behavioral screen for mediators of age-dependent TDP-43 neurodegeneration identifies SF2/SRSF1 among a group of potent suppressors in both neurons and glia.
Jorge Azpurua, Enas A. Elkarim, … Josh Dubnau·PLoS GeneticsPeer-reviewed·Nov 1, 2021
- Common Dysregulated Pathways and Genes in Alzheimer's, Parkinson's, and Huntington's Diseases: A Computational Analysis to Nominate Candidate Gene Targets for Drug Repurposing
Nehal Adel Abdelsalam, Muhammad Elsadany, Eman Badr·bioRxiv·Jul 25, 2026
- Neurotrophic and immunomodulatory lanostane triterpenoids from wood-inhabiting Basidiomycota
K. Hassan, B. M. Kemkuignou, … M. Stadler·bioRxiv·Oct 27, 2022